OSAS has a high prevalence and significant adverse consequences
PMID: 17083573
States must cover all medically necessary treatments for this age group including GLP-1s for obesity when a provider determines theyre medically necessary
This is one of the most popular multi-additive formulations
They have very stringent requirements for charging, discharging, storage, and disposal, and not observing these requirements can result in poor performance, reduced battery lifespan, or even a fire or explosion
(Source: iPharma Pharmacy, 2026) A 2026 systematic review and meta-analysis (Prospero CRD42024535096) searched Cochrane Library, EMBASE, and Medline through September 2024, identifying 9,654 studies and including 11 randomized controlled trials comparing GLP-1 receptor agonists against no treatment, placebo, lifestyle intervention, oral contraceptives, anti-androgens, or metformin in PCOS patients